MMP mediated degradation of type IV collagen alpha 1 and alpha 3 chains reflects basement membrane remodeling in experimental and clinical fibrosis - Validation of two novel biomarker assays

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Sand, Jannie Marie ^a   Larsen, Lise ^a   Hogaboam, Cory ^b   Martinez, Fernando ^c   Han, MeiLan ^c   Larsen, Martin Roøssel ^d   Nawrocki, Arkadiusz ^d   Zheng, Qinlong ^e   Karsdal, Morten Asser ^a   Leeming, Diana Julie ^a  

^a Fibrosis Biology and Biomarkers   (Denmark)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^e Nordic Bioscience Beijing   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYSIS OF VARIANCE; ANIMALS; AUTOANTIGENS; BASEMENT MEMBRANE; CARBON TETRACHLORIDE; COLLAGEN TYPE IV; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LIVER CIRRHOSIS; MASS SPECTROMETRY; MATRIX METALLOPROTEINASE 12; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY FIBROSIS; RATS;

EID: 84893320758     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0084934     Document Type: Article

References (62)

1. Wynn TA (2008) Cellular and molecular mechanisms of fibrosis. J Pathol 214: 199-210. doi:10.1002/path.2277. PubMed: 18161745.
2. Kisseleva T, Brenner DA (2008) Fibrogenesis of parenchymal organs. Proc Am Thorac Soc 5: 338-342. doi:10.1513/pats.200711-168DR. PubMed: 18403330.
3. Stamenkovic I (2003) Extracellular matrix remodelling: the role of matrix metalloproteinases. J Pathol 200: 448-464. doi:10.1002/path.1400. PubMed: 12845612.
4. Shapiro SD (1998) Matrix metalloproteinase degradation of extracellular matrix: biological consequences. Curr Opin Cell Biol 10: 602-608. doi:10.1016/S0955-0674(98)80035-5. PubMed: 9818170.
5. Lagente V, Manoury B, Nénan S, Le QC, Martin-Chouly C et al. (2005) Role of matrix metalloproteinases in the development of airway inflammation and remodeling. Braz J Med Biol Res 38: 1521-1530. doi:10.1590/S0100-879X2005001000009. PubMed: 16172745. (Pubitemid 41440223)
6. Pardo A, Selman M (2006) Matrix metalloproteases in aberrant fibrotic tissue remodeling. Proc Am Thorac Soc 3: 383-388. doi:10.1513/pats.200601-012TK. PubMed: 16738205.
7. Pardo A, Selman M, Kaminski N (2008) Approaching the degradome in idiopathic pulmonary fibrosis. Int J Biochem Cell Biol 40: 1141-1155. doi:10.1016/j.biocel.2007.11.020. PubMed: 18207447.
8. Han YP (2006) Matrix metalloproteinases, the pros and cons, in liver fibrosis. J Gastroenterol Hepatol 21 Suppl 3: S88-S91. doi:10.1111/j.1440-1746. 2006.04405.x. PubMed: 16958682.
9. Yurchenco PD (2011) Basement membranes: cell scaffoldings and signaling platforms. Cold Spring Harb Perspect Biol 3: ([MedlinePgn:]) PubMed: 21421915.
10. Kruegel J, Miosge N (2010) Basement membrane components are key players in specialized extracellular matrices. Cell Mol Life Sci 67: 2879-2895. doi:10.1007/s00018-010-0367-x. PubMed: 20428923.
11. Kalluri R (2003) Basement membranes: structure, assembly and role in tumour angiogenesis. Nat Rev Cancer 3: 422-433. doi:10.1038/nrc1094. PubMed: 12778132.
12. Hohenester E, Yurchenco PD (2013) Laminins in basement membrane assembly. Cell Adh Migr 7: 56-63. doi:10.4161/cam.21831. PubMed: 23076216.
13. Hudson BG, Reeders ST, Tryggvason K (1993) Type IV collagen: structure, gene organization, and role in human diseases. Molecular basis of Goodpasture and Alport syndromes and diffuse leiomyomatosis. J Biol Chem 268: 26033-26036. PubMed: 8253711. (Pubitemid 23361657)
14. Mariyama M, Leinonen A, Mochizuki T, Tryggvason K, Reeders ST (1994) Complete primary structure of the human alpha 3(IV) collagen chain. Coexpression of the alpha 3(IV) and alpha 4(IV) collagen chains in human tissues. J Biol Chem 269: 23013-23017. PubMed: 8083201.
15. Miner JH, Sanes JR (1994) Collagen IV alpha 3, alpha 4, and alpha 5 chains in rodent basal laminae: sequence, distribution, association with laminins, and developmental switches. J Cell Biol 127: 879-891. doi:10.1083/jcb.127.3.879. PubMed: 7962065.
16. Hudson BG, Tryggvason K, Sundaramoorthy M, Neilson EG (2003) Alport's syndrome, Goodpasture's syndrome, and type IV collagen. N Engl J Med 348: 2543-2556. doi:10.1056/NEJMra022296. PubMed: 12815141. (Pubitemid 36706542)
17. Kalluri R, Shield CF, Todd P, Hudson BG, Neilson EG (1997) Isoform switching of type IV collagen is developmentally arrested in X-linked Alport syndrome leading to increased susceptibility of renal basement membranes to endoproteolysis. J Clin Invest 99: 2470-2478. doi:10.1172/JCI119431. PubMed: 9153291. (Pubitemid 27227726)
18. Wynn TA (2007) Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J Clin Invest 117: 524-529. doi:10.1172/JCI31487. PubMed: 17332879.
19. Corbel M, Theret N, Caulet-Maugendre S, Germain N, Lagente V et al. (2001) Repeated endotoxin exposure induces interstitial fibrosis associated with enhanced gelatinase (MMP-2 and MMP-9) activity. Inflamm Res 50: 129-135. doi:10.1007/s000110050736. PubMed: 11339500. (Pubitemid 32242701)
20. Shapiro SD, Kobayashi DK, Ley TJ (1993) Cloning and characterization of a unique elastolytic metalloproteinase produced by human alveolar macrophages. J Biol Chem 268: 23824-23829. PubMed: 8226919. (Pubitemid 23335353)
21. Shipley JM, Wesselschmidt RL, Kobayashi DK, Ley TJ, Shapiro SD (1996) Metalloelastase is required for macrophage-mediated proteolysis and matrix invasion in mice. Proc Natl Acad Sci U S A 93: 3942-3946. doi:10.1073/pnas.93.9. 3942. PubMed: 8632994. (Pubitemid 26144227)
22. Chandler S, Cossins J, Lury J, Wells G (1996) Macrophage metalloelastase degrades matrix and myelin proteins and processes a tumour necrosis factor-alpha fusion protein. Biochem Biophys Res Commun 228: 421-429. doi:10.1006/bbrc.1996. 1677. PubMed: 8920930. (Pubitemid 26396090)
23. Gioia M, Monaco S, Van Den Steen PE, Sbardella D, Grasso G et al. (2009) The collagen binding domain of gelatinase A modulates degradation of collagen IV by gelatinase B. J Mol Biol 386: 419-434. doi:10.1016/j.jmb.2008.12.021. PubMed: 19109975.
24. Monaco S, Sparano V, Gioia M, Sbardella D, Di PD et al. (2006) Enzymatic processing of collagen IV by MMP-2 (gelatinase A) affects neutrophil migration and it is modulated by extracatalytic domains. Protein Sci 15: 2805-2815. doi:10.1110/ps.062430706. PubMed: 17088321. (Pubitemid 44833761)
25. Karsdal MA, Henriksen K, Leeming DJ, Woodworth T, Vassiliadis E et al. (2010) Novel combinations of Post-Translational Modification (PTM) neo-epitopes provide tissue-specific biochemical markers - are they the cause or the consequence of the disease? Clin Biochem 43: 793-804. doi:10.1016/j.clinbiochem. 2010.03.015. PubMed: 20381482.
26. Henriksen K, Christiansen C, Karsdal MA (2011) Serological biochemical markers of surrogate efficacy and safety as a novel approach to drug repositioning. Drug Discov Today 16: 967-975. doi:10.1016/j.drudis.2011.06.010. PubMed: 21745584.
27. Leeming DJ, Larsen DV, Zhang C, Hi Y, Veidal SS et al. (2010) Enzyme-linked immunosorbent serum assays (ELISAs) for rat and human N-terminal pro-peptide of collagen type I (PINP) - assessment of corresponding epitopes. Clin Biochem 43: 1249-1256. doi:10.1016/j.clinbiochem.2010.07.025. PubMed: 20709044.
28. Rosenquist C, Fledelius C, Christgau S, Pedersen BJ, Bonde M et al. (1998) Serum CrossLaps One Step ELISA. First application of monoclonal antibodies for measurement in serum of bone-related degradation products from C-terminal telopeptides of type I collagen. Clin Chem 44: 2281-2289. PubMed: 9799755. (Pubitemid 28511750)
29. Leeming DJ, He Y, Veidal S, Nguyen Q, Larsen D et al. (2011) A novel marker for assessment of liver matrix remodeling: an enzyme-linked immunosorbent assay (ELISA) detecting a MMP generated type I collagen neo-epitope (C1M). Biomarkers 16: 616-628. doi:10.3109/1354750X.2011.620628. PubMed: 21988680.
30. Thingholm TE, Larsen MR (2009) The use of titanium dioxide microcolumns to selectively isolate phosphopeptides from proteolytic digests. Methods Mol Biol 527: 57-66, xi
31. Combet C, Blanchet C, Geourjon C, Deléage G (2000) NPS@: network protein sequence analysis. Trends Biochem Sci 25: 147-150. doi:10.1016/S0968- 0004(99)01540-6. PubMed: 10694887. (Pubitemid 30122428)
32. Gefter ML, Margulies DH, Scharff MD (1977) A simple method for polyethylene glycol-promoted hybridization of mouse myeloma cells. Somatic Cell Genet 3: 231-236. doi:10.1007/BF01551818. PubMed: 605383. (Pubitemid 8133604)
33. Segovia-Silvestre T, Reichenbach V, Fernández-Varo G, Vassiliadis E, Barascuk N et al. (2011) Circulating CO3-610, a degradation product of collagen III, closely reflects liver collagen and portal pressure in rats with fibrosis. Fibrogenesis Tissue Repair 4: 19. doi:10.1186/1755-1536-4-19. PubMed: 21813019.
34. Clària J, Jimenez W (1999) Renal dysfunction and ascites in carbon tetrachloride-induced cirrhosis in rats. In: V ArroyoRW SchrierJ RodésP Ginès. The Liver and the Kidney. Boston: Blackwell Science. pp. 379-396.
35. Muñoz-Luque J, Ros J, Fernández-Varo G, Tugues S, Morales-Ruiz M et al. (2008) Regression of fibrosis after chronic stimulation of cannabinoid CB2 receptor in cirrhotic rats. J Pharmacol Exp Ther 324: 475-483. PubMed: 18029545.
36. Ruiz S, Henschen-Edman AH, Nagase H, Tenner AJ (1999) Digestion of C1q collagen-like domain with MMPs-1,-2,-3, and -9 further defines the sequence involved in the stimulation of neutrophil superoxide production. J Leukoc Biol 66: 416-422. PubMed: 10496311. (Pubitemid 29439248)
37. Mackay AR, Hartzler JL, Pelina MD, Thorgeirsson UP (1990) Studies on the ability of 65-kDa and 92-kDa tumor cell gelatinases to degrade type IV collagen. J Biol Chem 265: 21929-21934. PubMed: 2174891. (Pubitemid 120014244)
38. Garnero P, Borel O, Byrjalsen I, Ferreras M, Drake FH et al. (1998) The collagenolytic activity of cathepsin K is unique among mammalian proteinases. J Biol Chem 273: 32347-32352. doi:10.1074/jbc.273.48.32347. PubMed: 9822715. (Pubitemid 29177183)
39. Gioia M, Fasciglione GF, Monaco S, Iundusi R, Sbardella D et al. (2010) pH dependence of the enzymatic processing of collagen I by MMP-1 (fibroblast collagenase), MMP-2 (gelatinase A), and MMP-14 ectodomain. J Biol Inorg Chem 15: 1219-1232. doi:10.1007/s00775-010-0680-8. PubMed: 20549272.
40. Sukhova GK, Schönbeck U, Rabkin E, Schoen FJ, Poole AR et al. (1999) Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques. Circulation 99: 2503-2509. doi:10.1161/01.CIR.99.19.2503. PubMed: 10330380.
41. Billinghurst RC, Dahlberg L, Ionescu M, Reiner A, Bourne R et al. (1997) Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. J Clin Invest 99: 1534-1545. doi:10.1172/JCI119316. PubMed: 9119997. (Pubitemid 27163804)
42. Billinghurst RC, Ionescu M, Poole AR (2010) Immunoassays for collagenase-mediated cleavage of type I and II collagens. Methods Mol Biol 622: 349-366. doi:10.1007/978-1-60327-299-5-21. PubMed: 20135293.
43. Risteli J, Rohde H, Timpl R (1981) Sensitive radioimmunoassays for 7 S collagen and laminin: application to serum and tissue studies of basement membranes. Anal Biochem 113: 372-378. doi:10.1016/0003-2697(81)90091-9. PubMed: 7283141. (Pubitemid 11012544)
44. Högemann B, Voss B, Pott G, Rauterberg J, Gerlach U (1984) 7 S collagen: a method for the measurement of serum concentrations in man. Clin Chim Acta 144: 1-10. doi:10.1016/0009-8981(84)90254-7. PubMed: 6542469.
45. Schuppan D, Besser M, Schwarting R, Hahn EG (1986) Radioimmunoassay for the carboxy-terminal cross-linking domain of type IV (basement membrane) procollagen in body fluids. Characterization and application to collagen type IV metabolism in fibrotic liver disease. J Clin Invest 78: 241-248. doi:10.1172/JCI112557. PubMed: 3722378. (Pubitemid 16068205)
46. Niemelä O, Risteli L, Sotaniemi EA, Risteli J (1985) Type IV collagen and laminin-related antigens in human serum in alcoholic liver disease. Eur J Clin Invest 15: 132-137. doi:10.1111/j.1365-2362.1985.tb00156.x. PubMed: 3926506.
47. Matsumoto E, Muragaki Y, Ooshima A (1989) Increased amount of serum type IV collagen peptide in human liver fibrosis as determined by enzyme-immunoassay with monoclonal antibodies. Acta Pathol Jpn 39: 217-223. PubMed: 2472734. (Pubitemid 19156646)
48. Veidal SS, Karsdal MA, Nawrocki A, Larsen MR, Dai Y et al. (2011) Assessment of proteolytic degradation of the basement membrane: a fragment of type IV collagen as a biochemical marker for liver fibrosis. Fibrogenesis Tissue Repair 4: 22. doi:10.1186/1755-1536-4-22. PubMed: 21970406.
49. Leeming DJ, Nielsen MJ, Dai Y, Veidal SS, Vassiliadis E et al. (2012) Enzyme-linked immunosorbent serum assay specific for the 7S domain of Collagen Type IV (P4NP 7S): A marker related to the extracellular matrix remodeling during liver fibrogenesis. Hepatol Res, 42: 482-93. PubMed: 22221767.
50. Obata K, Iwata K, Ichida T, Inoue K, Matsumoto E et al. (1989) One step sandwich enzyme immunoassay for human type IV collagen using monoclonal antibodies. Clin Chim Acta 181: 293-303. doi:10.1016/0009-8981(89)90235-0. PubMed: 2547537.
51. Luo YQ, Li J, Zhao L, Sun AY, Dong H et al. (2010) Development of an ELISA for quantification of tumstatin in serum samples and tissue extracts of patients with lung carcinoma. Clin Chim Acta 411: 510-515. doi:10.1016/j.cca. 2010.01.001. PubMed: 20064495.
52. Karsdal MA, Delvin E, Christiansen C (2011) Protein fingerprints - relying on and understanding the information of serological protein measurements. Clin Biochem 44: 1278-1279. doi:10.1016/j.clinbiochem.2011.08. 1135. PubMed: 21907191.
53. Murawaki Y, Ikuta Y, Koda M, Yamada S, Kawasaki H (1996) Comparison of serum 7S fragment of type IV collagen and serum central triple-helix of type IV collagen for assessment of liver fibrosis in patients with chronic viral liver disease. J Hepatol 24: 148-154. doi:10.1016/S0168-8278(96)80023-7. PubMed: 8907567. (Pubitemid 26057951)
54. Kasuga I, Yonemaru M, Kiyokawa H, Ichinose Y, Toyama K (1996) Clinical evaluation of serum type IV collagen 7S in idiopathic pulmonary fibrosis. Respirology 1: 277-281. doi:10.1111/j.1440-1843.1996.tb00043.x. PubMed: 9441116.
55. Kawamura M, Yamasawa F, Ishizaka A, Kato R, Kikuchi K et al. (1994) Serum concentration of 7S collagen and prognosis in patients with the adult respiratory distress syndrome. Thorax 49: 144-146. doi:10.1136/thx.49.2.144. PubMed: 8128404.
56. Matsumoto E, Muragaki Y, Ooshima A (1989) Increased serum type IV collagen peptide in carbon tetrachloride-treated rats. Acta Pathol Jpn 39: 23-29. PubMed: 2711835. (Pubitemid 19085396)
57. Neubauer K, Krüger M, Quondamatteo F, Knittel T, Saile B et al. (1999) Transforming growth factor-beta1 stimulates the synthesis of basement membrane proteins laminin, collagen type IV and entactin in rat liver sinusoidal endothelial cells. J Hepatol 31: 692-702. doi:10.1016/S0168-8278(99)80350-X. PubMed: 10551394.
58. Morrison KE, Mariyama M, Yang-Feng TL, Reeders ST (1991) Sequence and localization of a partial cDNA encoding the human alpha 3 chain of type IV collagen. Am J Hum Genet 49: 545-554. PubMed: 1882840. (Pubitemid 21891699)
59. Salazar LM, Herrera AM (2011) Fibrotic response of tissue remodeling in COPD. Lung 189: 101-109. doi:10.1007/s00408-011-9279-2. PubMed: 21287182.
60. O'Reilly PJ, Gaggar A, Blalock JE (2008) Interfering with extracellular matrix degradation to blunt inflammation. Curr Opin Pharmacol 8: 242-248. doi:10.1016/j.coph.2008.02.003. PubMed: 18346936.
61. King TE Jr., Pardo A, Selman M (2011) Idiopathic pulmonary fibrosis. Lancet 378: 1949-1961. doi:10.1016/S0140-6736(11)60052-4. PubMed: 21719092.
62. Bringardner BD, Baran CP, Eubank TD, Marsh CB (2008) The role of inflammation in the pathogenesis of idiopathic pulmonary fibrosis. Antioxid Redox Signal 10: 287-301. doi:10.1089/ars.2007.1897. PubMed: 17961066.